NCT00527501已完成2 期
IOP Lowering Efficacy of Travoprost/Brinzolamide Fixed Combination Ophthalmic Suspension in Patients With Open-Angle Glaucoma or Ocular Hypertension
适应症
相关药物
试验速览
- 阶段
- 2 期
- 状态
- 已完成
- 入组人数
- 136
- 试验地点
- 2
- 主要终点
- Mean IOP
研究概览
简要总结
The purpose of this study is to compare the safety and IOP-lowering efficacy of a fixed combination of Travoprost/Brinzolamide Ophthalmuc Suspension dosed BID and QD, to TRAVATAN dosed QD and a Vehicle dosed BID in patients with open-angle glaucoma or ocular hypertension.
研究设计
- 研究类型
- Interventional
- 分配方式
- Randomized
- 干预模型
- Parallel
- 主要目的
- Treatment
- 盲法
- Double
入排标准
- 年龄范围
- 18 Years 至 —（Adult, Older Adult）
- 性别
- All
- 接受健康志愿者
- 否
入选标准
- •Patients 18 years of age or older of either sex and any race with diagnosed open-angle glaucoma or confirmed ocular hypertension
排除标准
- •Age (Under 18)
结局指标
主要结局
Mean IOP
时间窗: Time
次要结局
未报告次要终点
研究者
研究点 (2)
Loading locations...
相似试验
终止
3 期
Travoprost/Brinzolamide Fixed Combination Versus Travatan and Versus AZOPTGlaucomaOcular HypertensionNCT00767494Alcon Research17
已完成
2 期
Travoprost New Formulations in Patients With Open-Angle Glaucoma or Ocular HypertensionOpen-angle GlaucomaOcular HypertensionNCT00670033Alcon Research158
已完成
4 期
A Phase IV Study of Travoprost + Brinzolamide to Treat Glaucoma or Ocular HypertensionGlaucomaOcular HypertensionNCT00471380Alcon Research46
已完成
3 期
A Safety and Efficacy Study of Travoprost 0.004% Compared to Latanoprost 0.005% in Patients With Open-Angle Glaucoma (OAG) or Ocular Hypertension (OHT)Glaucoma, Open-AngleOcular HypertensionNCT00051142Alcon Research
已完成
4 期
Phase IV Randomised Double-masked Clinical Trial: Assessing Morning Versus Evening Dosing of a Fixed Dose Combination of Travoprost 0.004% / Timolol Maleate 0.5% in Patients With Primary Open-angle Glaucoma or Ocular HypertensionOpen-angle GlaucomaOcular HypertensionNCT00759239Alcon Research36